Skip to main content

Study explores third-line trabectedin plus PLD for BRCA1/2 ovarian cancer

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Study explores third-line trabectedin plus PLD for BRCA1/2 ovarian cancer

User login

Username

Password

Reset your password

Type	Lead	score